Unitaid transparency policy
Policy on ethics and conflict of interest for Unitaid
Unitaid’s climate and health strategy 2023-2027
Unitaid’s investment case 2023-2027, executive summary
Unitaid’s investment case 2023-2027
Unitaid Strategy 2023-2027
Maternal and newborn health
Women’s and children’s health
Biomarkers for acute febrile illness at the point-of-care in low-resource settings. Meeting report
Accelerating access to innovative point-of-care HIV diagnostics: Lessons learned from UNICEF
Innovative delivery systems for paediatric medicines technology landscape
Disease Narrative for hepatitis C
Disease narrative for tuberculosis
Disease Narrative for malaria
Disease Narrative for HIV
Hepatitis C diagnostics technology landscape – May 2019
Unitaid and the Government of Spain
About Unitaid (Saving lives faster)
Unitaid and the UK Government
Unitaid audited financial report for the year ended 31 December 2023
Partnership report: Unitaid and the Global Fund to Fight AIDS, Tuberculosis and Malaria
Unitaid audited financial report for the year ended 31 December 2022
Thematic Narrative for Reproductive, Maternal, Newborn and Child Health (RMNCH)
Global malaria diagnostic and artemisinin treatment commodities demand forecast: policy brief (April 2016)
Global malaria diagnostic and artemisinin treatment commodities demand forecast: 2015 – 2018 (April 2016)
Global malaria diagnostic and artemisinin treatment commodities demand forecast: forecasting methodology (April 2016)
Malaria diagnostics technology and market landscape: 3rd edition
Faster, cheaper, better ways to end HIV
Unitaid audited financial report for the year ended 31 December 2015
